Founder of GlycoMar. He is a biochemist with over 8 years experience in marine biotechnology. A graduate of the University of Edinburgh, he completed his Ph.D. at the same university, studying proteoglycan metabolism in cartilage. This was followed by postdoctoral research at Dunstaffnage marine lab studying invertebrate glycans and cell adhesion. Subsequently he worked for Integrin Advanced Biosystems Ltd, a marine biotechnology and testing company, holding the positions of Operations Manager and Drug Discovery Manager. His scientific interest is in glycobiology and its role in cell-cell interactions.
Mrs. Moya Crawford, Non-executive director.
Managing Director of Deeptek Ltd, a specialist underwater technology company. Moya Crawford was a Council member of The Scottish Association for Marine Science (SAMS) from 1999-2005 and Chairman of SAMS' commercial arm, SAMS Research Services Limited (SRSL) for its first three years of business. She is currently the Non-Executive Chairman of SMRU Ltd, a spin-out company from the Sea Mammal Research Unit as St Andrews University, and sits on the Council of the Society for Underwater Technology (SUT).
Dr Mike Wyllie, Non-executive director.
Dr Mike Wyllie, Director and Founder of Global Pharma Consulting Limited (GPC Ltd). He has over 25 years of experience in senior management level positions within the pharmaceutical industry including Wyeth and Pfizer. He co-founded Plethora Solutions Ltd. in 2003 which was successfully listed on the London Stock Exchange in March 2005 (AIM: PLE). He is also a non-executive director and CSO of the medical technology company, Zi Medical Plc, a non executive director of Taihua Plc and an executive director of Bactomed Limited.
Dr Jason Beckwith, Non-executive director.
Dr Jason Beckwith, Co-Director and Founder Evolution Life Science Limited, SquadD Ltd, Solis Ltd and Technologies for Health Ltd. He is MBA qualified, with 5 years academic experience and 15 years experience in Healthcare Business. He has held senior European Business Development, Licensing and Sales roles in blue chip and SME Healthcare companies including six years with the Invitrogen Corporation. Dr Jason Beckwith also serves on the Board of Directors for MDIS (Medical Devices in Scotland), T4H (Technologies for Health), MidgeTech, Solis BV, Molecular Tools Europe Ltd, SquadD Ltd and Pilot Pharma.
